Revenio Group Corporation:

Revenio Group Oyj

Stock Exchange Release, May 10, 2013 at 3.40 p.m.

NOTICE PURSUANT TO SECTION 9, CHAPTER 2 OF THE SECURITIES MARKET ACT

Revenio Group Corporation has today received a notification of change in
holdings in accordance with Chapter 2, Section 9 of the Securities Markets Act
that Joensuun Kauppa ja Kone Oy's share of the total number of shares and voting
rights in Revenio Group Corporation has exceeded one twentieth (1/20). Joensuun
Kauppa ja Kone Oy now holds 389.626 shares in Revenio Group Corporation, which
is 5,02 percent of the company's shares and voting rights.

The total number of Revenio Group Corporation's shares recorded in the trade
register is 7.768.909.

Olli-Pekka Salovaara
President and CEO

For further information, please contact:

Olli-Pekka Salovaara, President & CEO, +358 (0)40 567 5520 (mobile)
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi/

DISTRIBUTION:

NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Key media
www.revenio.fi

The Revenio Group in brief
Revenio is a Finnish health tech group whose core business are tonometers. The
Revenio Health Tech segment comprises the operations of Icare Finland Oy. The
widely patented Icare product family is the current cornerstone of the Group's
success. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.

In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4 percent. The Revenio Group Corporation is
listed on NASDAQ OMX Helsinki.